In a research report released today, Cowen’s healthcare analyst Ritu Baral reiterated an Outperform rating on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), and raised the price …
In a research report issued today, Cowen analyst Ritu Baral reiterated an Outperform rating on Amicus Therapeutics (NASDAQ:FOLD) with a $14 price target, following …
